연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
1881. Surgical safety and oncological completeness of robotic thyroidectomy for thyroid carcinoma larger than 2 cm.
Chai YJ, Suh H, Woo JW, Yu HW, Song RY, Kwon H, Lee KE.
Surg Endosc. 2016 Jul 15. [Epub ahead of print]
Link
1880. Significance of the BRAF mRNA Expression Level in Papillary Thyroid Carcinoma: An Analysis of The Cancer Genome Atlas Data.
Chai YJ, Yi JW, Jee HG, Kim YA, Kim JH, Xing M, Lee KE.
PLoS One. 2016 Jul 13;11(7):e0159235. doi: 10.1371/journal.pone.0159235. eCollection 2016.
Link
1879. A comparative study of postoperative pain for open thyroidectomy versus bilateral axillo-breast approach robotic thyroidectomy using a self-reporting application for iPad.
Chai YJ, Song J, Kang J, Woo JW, Song RY, Kwon H, Kim SJ, Choi JY, Lee KE.
Ann Surg Treat Res. 2016 May;90(5):239-45. doi: 10.4174/astr.2016.90.5.239. Epub 2016 May 2.
Link
1878. A novel lateral-approach laryngeal ultrasonography for vocal cord evaluation.
Woo JW, Suh H, Song RY, Lee JH, Yu HW, Kim SJ, Chai YJ, Choi JY, Lee KE.
Surgery. 2016 Jan;159(1):52-6. doi: 10.1016/j.surg.2015.07.043. Epub 2015 Sep 28.
Link
1877. TTP as a surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: meta-analysis of randomised controlled trials.
Lee DW, Jang MJ, Lee KH, Cho EJ, Lee JH, Yu SJ, Kim YJ, Yoon JH, Kim TY, Han SW, Oh DY, Im SA, Kim TY.
Br J Cancer. 2016 Nov 8;115(10):1201-1205. doi: 10.1038/bjc.2016.322. Epub 2016 Oct 13.
Link
1876. Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database.
Shin S, Park CM, Kwon H, Lee KH.
BMC Cancer. 2016 Jul 11;16:443. doi: 10.1186/s12885-016-2482-z.
Link
1875. Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer.
Suh KJ, Ryu HS, Lee KH, Kim H, Min A, Kim TY, Yang Y, Moon HG, Han SW, Oh DY, Han W, Park IA, Noh DY, Im SA.
Breast Cancer Res Treat. 2016 Jul;158(2):233-41. doi: 10.1007/s10549-016-3869-x. Epub 2016 Jun 21.
Link
1874. Prognostic Role of Body Mass Index in Advanced Small Bowel Adenocarcinoma Patients Receiving Palliative Chemotherapy.
Lee DW, Lee KH, Kim TY, Han SW, Oh DY, Im SA, Kim TY, Bang YJ.
Nutr Cancer. 2016 Jul;68(5):750-5. doi: 10.1080/01635581.2016.1180413. Epub 2016 Jun 9.
Link
1873. Visualization of exosome-mediated miR-210 transfer from hypoxic tumor cells.
Jung KO, Youn HW, Lee CH, Kang KW, Chung JK.
Oncotarget. 2016 Dec 27. doi: 10.18632/oncotarget.14247. [Epub ahead of print]
Link
1872. Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas.
Chung T, Na J, Kim YI, Chang DY, Kim YI, Kim H, Moon HE, Kang KW, Lee DS, Chung JK, Kim SS, Suh-Kim H, Paek SH, Youn HW.
Theranostics. 2016 Jun 17;6(10):1477-90. doi: 10.7150/thno.14158. eCollection 2016.
Link